2022 Update on Approved Therapeutic Agents for IBS-D and IBS-C

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

2022 Update on Approved Therapeutic Agents for IBS-D and IBS-C

By University of Louisville FEATURING Brooks Cash

0 views

January 24, 2023

FREE CME! This video is a part of the online version of the "Better Understand ...
read more ↘ the Symptoms and Care Options for Irritable Bowel Syndrome Seminars" brought to you through the joint providership of the University of Louisville and SC Liver Research Consortium. To claim free CME for this activity please follow this link https://cmetracker.net/ULOU/Publisher?page=pubOpen#/EventID/1282088/
↖ read less

Comments 3